HK1116337A1 - Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent - Google Patents

Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent

Info

Publication number
HK1116337A1
HK1116337A1 HK08106480.6A HK08106480A HK1116337A1 HK 1116337 A1 HK1116337 A1 HK 1116337A1 HK 08106480 A HK08106480 A HK 08106480A HK 1116337 A1 HK1116337 A1 HK 1116337A1
Authority
HK
Hong Kong
Prior art keywords
metered dose
sequestering agent
aerosol formulations
dose inhalers
pressurized metered
Prior art date
Application number
HK08106480.6A
Other languages
English (en)
Inventor
David Andrew Lewis
Brian John Meakin
Maurizio Delcanale
Fausto Pivetti
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36490097&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1116337(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of HK1116337A1 publication Critical patent/HK1116337A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
HK08106480.6A 2005-02-25 2008-06-12 Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent HK1116337A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05004233 2005-02-25
PCT/EP2006/001287 WO2006089656A2 (en) 2005-02-25 2006-02-13 Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent

Publications (1)

Publication Number Publication Date
HK1116337A1 true HK1116337A1 (en) 2008-12-19

Family

ID=36490097

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08106480.6A HK1116337A1 (en) 2005-02-25 2008-06-12 Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent

Country Status (23)

Country Link
US (1) US8877164B2 (ru)
EP (1) EP1850831B1 (ru)
JP (1) JP5259193B2 (ru)
KR (1) KR101313959B1 (ru)
CN (1) CN101119706B (ru)
AR (2) AR054230A1 (ru)
AU (1) AU2006218177B2 (ru)
BR (1) BRPI0607990A2 (ru)
CA (1) CA2594127C (ru)
EA (1) EA013405B1 (ru)
GE (1) GEP20105040B (ru)
HK (1) HK1116337A1 (ru)
IL (1) IL184449A0 (ru)
MA (1) MA29333B1 (ru)
MX (1) MX2007010396A (ru)
NO (1) NO20074854L (ru)
NZ (1) NZ556376A (ru)
PE (1) PE20061011A1 (ru)
SG (1) SG159550A1 (ru)
TN (1) TNSN07289A1 (ru)
UA (1) UA92732C2 (ru)
WO (1) WO2006089656A2 (ru)
ZA (1) ZA200706870B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE404185T1 (de) * 2004-05-13 2008-08-15 Chiesi Farma Spa Medizinische aerosolformulierungen mit verbesserter chemischer stabilität
GB201200525D0 (en) * 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
RU2519653C1 (ru) * 2013-02-27 2014-06-20 Шолекс Девелопмент Гмбх, Аэрозольный препарат на основе ипратропия бромида для лечения заболеваний органов дыхания
US10034866B2 (en) * 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
US11642372B2 (en) 2020-05-01 2023-05-09 Tygrus, LLC Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
US11826382B2 (en) 2020-05-01 2023-11-28 Tygrus, LLC Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO117414B1 (ro) * 1992-12-09 2002-03-29 Jager Paul D Waterbury Compozitie farmaceutica de aerosol in solutie
ZA939195B (en) * 1992-12-09 1995-06-08 Boehringer Ingelheim Pharma Stabilized medicinal aerosol solution formulations
EP0735884B1 (en) 1993-12-20 2000-04-26 Minnesota Mining And Manufacturing Company Flunisolide aerosol formulations
BR9608721A (pt) * 1995-06-07 1999-10-13 Rhone Poulenc Rorer Pharma Composição farmacêutica, e, processo para tratar inflamação
EP0835098B1 (de) * 1995-06-27 2002-09-04 Boehringer Ingelheim Pharma KG Neue stabile arzneimittelzubereitung zur erzeugung treibgasfreier aerosole
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it) * 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
WO2001087203A1 (en) * 2000-05-17 2001-11-22 Chrysalis Technologies Incorporated Stabilized budesonide solution and method for making same
AU5070100A (en) * 2000-05-22 2001-12-03 Chiesi Farma Spa Stable pharmaceutical solution formulations for pressurised metered dose inhalers
MXPA04008372A (es) * 2002-03-01 2004-11-26 Chiesi Farma Spa Formulacion superfina de formoterol.
CN1646527A (zh) 2002-04-12 2005-07-27 贝林格尔英格海姆法玛两合公司 包含β模拟剂(BETAMIMETICS)及新颖抗胆碱酯酶的药物
US7417051B2 (en) * 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
DE10230769A1 (de) 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren
US20040058950A1 (en) * 2002-07-09 2004-03-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
DE10237739A1 (de) 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
WO2004033478A2 (en) * 2002-10-08 2004-04-22 Sepracor Inc. Fatty acid modified forms of glucocorticoids and their use as anti-inflammatory
EP1595531A1 (en) * 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers

Also Published As

Publication number Publication date
TNSN07289A1 (en) 2008-12-31
AU2006218177B2 (en) 2012-04-12
CN101119706B (zh) 2013-04-17
EP1850831A2 (en) 2007-11-07
EP1850831B1 (en) 2015-12-02
PE20061011A1 (es) 2006-12-08
CA2594127A1 (en) 2006-08-31
WO2006089656A3 (en) 2006-12-21
KR20070107002A (ko) 2007-11-06
KR101313959B1 (ko) 2013-10-02
US20060193785A1 (en) 2006-08-31
MX2007010396A (es) 2007-10-19
CA2594127C (en) 2013-10-15
AU2006218177A1 (en) 2006-08-31
EA013405B1 (ru) 2010-04-30
ZA200706870B (en) 2008-11-26
JP2008537729A (ja) 2008-09-25
US8877164B2 (en) 2014-11-04
NZ556376A (en) 2010-01-29
UA92732C2 (ru) 2010-12-10
MA29333B1 (fr) 2008-03-03
GEP20105040B (en) 2010-07-12
BRPI0607990A2 (pt) 2009-10-27
SG159550A1 (en) 2010-03-30
WO2006089656A2 (en) 2006-08-31
JP5259193B2 (ja) 2013-08-07
AR099963A2 (es) 2016-08-31
AR054230A1 (es) 2007-06-13
NO20074854L (no) 2007-09-24
EA200701805A1 (ru) 2008-02-28
IL184449A0 (en) 2007-10-31
CN101119706A (zh) 2008-02-06

Similar Documents

Publication Publication Date Title
ZA200808965B (en) Pharmaceutical solution formulations for pressurised metered dose inhalers
HUS1800032I1 (hu) Gyógyászati célú stabil aeroszol összetétel, inhalátor az aeroszol pontos adagolásához és eljárás ennek feltöltésére
BRPI0507225A2 (pt) formulações estáveis de solução farmacêutica para inaladores pressurizados de dose medida
HK1101346A1 (en) Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient
IL187209A0 (en) Dose counter for metered dose inhalers
IL185390A0 (en) A solid pharmaceutical dosage formulation
IL193776A0 (en) A pharmaceutical composition containing an aminosalicylate active agent
AP2007004247A0 (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
ZA200801676B (en) Mechanical doses counter for a powder inhaler
HK1116337A1 (en) Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
ZA200707513B (en) Dispenser for delivering medicament
ZA200709788B (en) Cannabinold active pharmaceutical ingredient for Improved dosage forms
GB0515478D0 (en) Canister-supported gauge-type count readout assembly for a metered dose inhaler
HK1103280A1 (en) Stable pharmaceutical solution formulations for pressurized metered dose inhalers
ZA200606577B (en) Stable pharmaceutical solution formulations for pressurized metered dose inhalers
GB2406096B (en) A pharmaceutical metered dose aerosol inhaler device
AU2005907076A0 (en) A stand-alone mechanical counter that fits onto existing pressurised Metered Dose Inhalers(pMDIs) used to deliver medication to the lungs

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170213